New Healthcare Claims Study Published in CNS Spectrums Finds High Rates of Treatment Switching, Discontinuation, and Prolonged Gaps in Care Among Patients with Generalized Anxiety Disorder (GAD)

Go back to New Healthcare Claims Study Published in CNS Spectrums Finds High Rates of Treatment Switching, Discontinuation, and Prolonged Gaps in Care Among Patients with Generalized Anxiety Disorder (GAD)
(NASDAQ: DFTX) Delayed: 43.67 -1.41 (3.13%)
Previous Close $45.08    52 Week High
Open $44.02    52 Week Low
Day High $44.99    P/E N/A 
Day Low $43.53    EPS
Volume 1,239,538